The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Penpulimab plus gemcitabine in combination with cisplatin or anlotinib as first-line treatment for metastatic nasopharyngeal carcinoma (M NPC): A phase II study.
 
Shuang Huang
No Relationships to Disclose
 
Xiaozhong Chen
No Relationships to Disclose
 
Song Qu
No Relationships to Disclose
 
Shenhong Qu
No Relationships to Disclose
 
Yaqian Han
No Relationships to Disclose
 
Kunyu Yang
No Relationships to Disclose
 
Shiting Huang
No Relationships to Disclose
 
Min Li
No Relationships to Disclose
 
Lin Zhang
No Relationships to Disclose
 
Qian Ding
No Relationships to Disclose